Abcuro Secures $200M Series C to Advance Ulviprubart for IBM
Key Highlights Abcuro raises $200M in Series C funding led by New Enterprise Associates (NEA) with participation from…
Browsing Tag
abrdn Inc
2 posts
Qlaris Bio Secures $24M in Series B Funding for Eye Disease Treatment
Key Highlights $24 million Series B funding co-led by Canaan and New Leaf Venture Partners. Funds to support Phase II trials of…